AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN501.74-6.42 (-1.26%) ▼|LLY1,366.97+78.67 (+6.11%) ▲|LMT647.45+17.70 (+2.81%) ▲|LOW204.60+6.20 (+3.13%) ▲|LRCX254.08+0.26 (+0.10%) ▲|MA635.88+25.57 (+4.19%) ▲|MCD256.22+5.72 (+2.28%) ▲|MDLZ62.35+0.48 (+0.77%) ▲|MDT97.11+2.33 (+2.45%) ▲|META627.07+14.58 (+2.38%) ▲|MMM176.58+3.78 (+2.19%) ▲|MO75.78+2.79 (+3.82%) ▲|MRK146.72+5.79 (+4.11%) ▲|MS190.39+0.26 (+0.14%) ▲|MSFT529.63-1.38 (-0.26%) ▼|MU932.81-50.42 (-5.13%) ▼|NEE81.97+0.95 (+1.17%) ▲|NFLX61.89-0.10 (-0.16%) ▼|NKE38.24+1.09 (+2.92%) ▲|NOW109.74-40.40 (-26.91%) ▼|NVDA212.80-2.59 (-1.20%) ▼|ORCL138.21-6.33 (-4.38%) ▼|PEP133.35+0.72 (+0.54%) ▲|PFE29.62+0.17 (+0.56%) ▲|PG159.75+1.49 (+0.94%) ▲|PLTR194.27-2.54 (-1.29%) ▼|PM207.51+4.87 (+2.40%) ▲|QCOM183.71+0.74 (+0.40%) ▲|RTX200.81+4.97 (+2.54%) ▲|SBUX103.91+0.71 (+0.68%) ▲|SCHW89.22+0.46 (+0.52%) ▲|SO93.12+1.60 (+1.74%) ▲|SPG215.00+3.76 (+1.78%) ▲|T20.95+0.25 (+1.18%) ▲|TMO704.26+0.11 (+0.01%) ▲|TMUS148.11+0.03 (+0.02%) ▲|TSLA405.56+1.34 (+0.33%) ▲|TXN308.24-1.59 (-0.51%) ▼|UBER65.07-0.20 (-0.31%) ▼|UNH404.96-2.14 (-0.53%) ▼|UNP300.57+2.77 (+0.93%) ▲|UPS106.68+1.06 (+1.00%) ▲|USB60.29+0.69 (+1.15%) ▲|V410.49+9.89 (+2.47%) ▲|VZ43.72+0.54 (+1.24%) ▲|WFC84.60+0.93 (+1.11%) ▲|WMT121.19+2.42 (+2.03%) ▲|XOM182.37+0.35 (+0.19%) ▲|AAPL349.81+5.98 (+1.74%) ▲|ABBV288.72+2.73 (+0.95%) ▲|ABT103.72+1.08 (+1.05%) ▲|ACN246.26+2.86 (+1.18%) ▲|ADBE247.48-2.28 (-0.91%) ▼|AMAT423.89+7.89 (+1.90%) ▲|AMD564.68-13.76 (-2.38%) ▼|AMGN458.62+6.79 (+1.50%) ▲|AMT185.35+1.60 (+0.87%) ▲|AMZN244.78-9.82 (-3.86%) ▼|AVGO344.60-7.21 (-2.05%) ▼|AXP323.85+5.91 (+1.86%) ▲|BA172.66+5.52 (+3.30%) ▲|BAC51.36+0.51 (+0.99%) ▲|BKNG149.26+1.32 (+0.89%) ▲|BLK1,167.49+9.61 (+0.83%) ▲|BMY60.34-0.24 (-0.39%) ▼|BNY149.22+0.63 (+0.42%) ▲|BRK-B543.76+3.42 (+0.63%) ▲|C125.35+1.24 (+1.00%) ▲|CAT646.56-66.82 (-9.37%) ▼|CL92.66+0.97 (+1.06%) ▲|CMCSA22.03+0.46 (+2.11%) ▲|COF208.38+3.50 (+1.71%) ▲|COP149.74+0.68 (+0.46%) ▲|COST992.41+9.68 (+0.98%) ▲|CRM231.39-10.72 (-4.43%) ▼|CSCO108.59-1.70 (-1.54%) ▼|CVS89.61-0.34 (-0.38%) ▼|CVX230.85+1.65 (+0.72%) ▲|DE657.20+16.53 (+2.58%) ▲|DHR234.76+0.69 (+0.29%) ▲|DIS110.84+1.80 (+1.65%) ▲|DUK125.67+2.10 (+1.70%) ▲|EMR169.81+2.10 (+1.25%) ▲|FDX307.07+2.49 (+0.82%) ▲|GD369.16+14.81 (+4.18%) ▲|GE311.05+9.92 (+3.29%) ▲|GEV889.06+11.03 (+1.26%) ▲|GILD161.32+2.12 (+1.33%) ▲|GM85.33+2.85 (+3.45%) ▲|GOOG279.85-42.04 (-13.06%) ▼|GOOGL281.79-43.11 (-13.27%) ▼|GS927.10+1.93 (+0.21%) ▲|HD325.63+8.07 (+2.54%) ▲|HON221.89+2.63 (+1.20%) ▲|IBM255.40+2.18 (+0.86%) ▲|INTC91.33-4.20 (-4.40%) ▼|INTU329.97+1.78 (+0.54%) ▲|ISRG448.52+4.34 (+0.98%) ▲|JNJ274.09+3.05 (+1.13%) ▲|JPM342.57+3.27 (+0.96%) ▲|KO92.46+0.73 (+0.79%) ▲|LIN501.74-6.42 (-1.26%) ▼|LLY1,366.97+78.67 (+6.11%) ▲|LMT647.45+17.70 (+2.81%) ▲|LOW204.60+6.20 (+3.13%) ▲|LRCX254.08+0.26 (+0.10%) ▲|MA635.88+25.57 (+4.19%) ▲|MCD256.22+5.72 (+2.28%) ▲|MDLZ62.35+0.48 (+0.77%) ▲|MDT97.11+2.33 (+2.45%) ▲|META627.07+14.58 (+2.38%) ▲|MMM176.58+3.78 (+2.19%) ▲|MO75.78+2.79 (+3.82%) ▲|MRK146.72+5.79 (+4.11%) ▲|MS190.39+0.26 (+0.14%) ▲|MSFT529.63-1.38 (-0.26%) ▼|MU932.81-50.42 (-5.13%) ▼|NEE81.97+0.95 (+1.17%) ▲|NFLX61.89-0.10 (-0.16%) ▼|NKE38.24+1.09 (+2.92%) ▲|NOW109.74-40.40 (-26.91%) ▼|NVDA212.80-2.59 (-1.20%) ▼|ORCL138.21-6.33 (-4.38%) ▼|PEP133.35+0.72 (+0.54%) ▲|PFE29.62+0.17 (+0.56%) ▲|PG159.75+1.49 (+0.94%) ▲|PLTR194.27-2.54 (-1.29%) ▼|PM207.51+4.87 (+2.40%) ▲|QCOM183.71+0.74 (+0.40%) ▲|RTX200.81+4.97 (+2.54%) ▲|SBUX103.91+0.71 (+0.68%) ▲|SCHW89.22+0.46 (+0.52%) ▲|SO93.12+1.60 (+1.74%) ▲|SPG215.00+3.76 (+1.78%) ▲|T20.95+0.25 (+1.18%) ▲|TMO704.26+0.11 (+0.01%) ▲|TMUS148.11+0.03 (+0.02%) ▲|TSLA405.56+1.34 (+0.33%) ▲|TXN308.24-1.59 (-0.51%) ▼|UBER65.07-0.20 (-0.31%) ▼|UNH404.96-2.14 (-0.53%) ▼|UNP300.57+2.77 (+0.93%) ▲|UPS106.68+1.06 (+1.00%) ▲|USB60.29+0.69 (+1.15%) ▲|V410.49+9.89 (+2.47%) ▲|VZ43.72+0.54 (+1.24%) ▲|WFC84.60+0.93 (+1.11%) ▲|WMT121.19+2.42 (+2.03%) ▲|XOM182.37+0.35 (+0.19%) ▲|
19.4 C
New York
Thursday, October 29, 2026

Tag: pharmaceutical

newsFORsourcecompanycontentinformationreleases1market

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

Cancer Therapeutics Market Forecast to Reach $168 Billion by 2029, Highlighting Recurrent and Metastatic Innovations

"Metastatic Cancer: A Significant Therapeutic Challenge as Pharmaceutical Companies Leverage Digital Platforms and Data to Enhance Engagement with Patients, Providers, and Regulators in the...

Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery

PWR delivers science-driven cellular energy and recovery support as part of Jupiter’s expanding longevity supplement portfolio

Morton Salt Announces Major Expansion

OVERLAND PARK, Kan., June 30, 2025 /PRNewswire/ -- Morton Salt (a/k/a SCIH Salt Holdings Inc.) today announced that its Consumer segment will significantly increase its...

Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for Bioproduction REDDING, Calif., June 30, 2025 /PRNewswire/ --According to a...

Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for Bioproduction REDDING, Calif., June 30, 2025 /PRNewswire/ --According to a...

CustomerInsights.AI (CIAI) Launches ciATHENA: A Conversational, Agentic AI Platform Redefining Pharma Commercial Analytics

PHOENIX, June 30, 2025 /PRNewswire/ -- Last week CIAI announced the launch of ciATHENA, a next generation Agentic AI platform built to accelerate commercial...

Total number of shares and voting rights in Zealand Pharma as of June 30, 2025

Company announcement – No. 16 / 2025

Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM, June 30, 2025 /PRNewswire/ -- Epigenica AB, a pioneer in high-throughput...

RDDT LAWSUIT DEADLINE: Suffer Losses on Reddit, Inc.? Contact BFA Law before the August 18 Securities Fraud Class Action Deadline (NYSE:RDDT)

Reddit, Inc. investors that lost money are notified to contact BFA Law before the August 18, 2025 securities fraud class action deadline.

PathAI Receives FDA Clearance for AISight® Dx Platform for Primary Diagnosis

BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings. Building on the initial 510(k) clearance for AISight Dx(Novo) in 2022, this latest milestone underscores the platform’s continuous innovation and PathAI’s commitment to delivering enhanced capabilities as the product evolves.

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceutical

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers